Christopher D. Alafi

Christopher D. Alafi, listed as board member, appears in our data through filings on Intra-Cellular Therapies, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 31 December 2015 to 27 May 2021, the count stands at 3 filings.

Sales make up the whole of the open-market record (2 sales, €314k). Outside the open market, there are 1 share grant. In 2021 alone, the filings show no purchases and 2 sales.

Most recently, on 28 May 2021, the filings show an open-market sale worth €278k in Intra-Cellular Therapies, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.